Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to hospital departments Infectious Diseases

Tuberculosis Department

Chinese People's Liberation Army General Hospital (301 Hospital)

Department of Tuberculosis Medicine The Department of Tuberculosis Medicine of the Eighth Medical Center is the only comprehensive department in the army that integrates clinical diagnosis and treatment of tuberculosis, preventive health care and scientific research and teaching. It is an important part of the national key discipline of Respiratory Medicine. It is a national key discipline for the treatment of tuberculosis with integrated traditional Chinese and Western medicine. It is the first batch of national key clinical specialty construction units in the army and the army's tuberculosis prevention and treatment technology. Guidance group leader unit, Army Acute Respiratory Infectious Disease Nursing Demonstration Base, Beijing Severe Respiratory Infectious Disease Treatment Base, Army Key Laboratory of Tuberculosis Prevention and Treatment, Beijing Key Laboratory of New Technology for Tuberculosis Diagnosis and Treatment, Beijing Haidian District Tuberculosis Prevention and Treatment Designated Institution, Beijing Area Tuberculosis Designated Point and Designated Treatment Structure for Pregnant Women with Tuberculosis. The academic department consists of two sub-specialties: Department of Tuberculosis, Tuberculosis Prevention and Control Team and Tuberculosis Research Institute. The annual outpatient volume reaches 40,000, and the number of inpatients reaches 3,000 per year. Undertakes a number of scientific research projects including major national infectious disease projects, National Natural Science and Technology Foundation, military and provincial and ministerial levels. Ranking third and fourth in China’s hospital science and technology impact rankings (tuberculosis). The new cryoprobe for bronchial interventional treatment has obtained an invention patent, which is the first of its kind in the domestic military and has complete intellectual property rights.

Remove this favorite?